PF-04603629

· Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-04603629, covering 2009-07-31 to 2009-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Single-Dose Study Of PF-04603629 In Type 2 Diabetic Subjects [Phase 1]